Gao Hui-Xin, Jiang Jun, Yang Chun-Yan, Xu Jin-Fu, He Qing, Hu Yan-Wei
Department of Clinical Laboratory, Guangzhou Women and Children Medical Center, Guangzhou Medical University, Guangzhou, Guangdong 510600, P.R. China.
Exp Ther Med. 2024 Jun 26;28(2):334. doi: 10.3892/etm.2024.12623. eCollection 2024 Aug.
Numerous studies have reported the potential involvement of ferroptosis in the development of atherosclerosis (AS). Acyl-CoA synthetase long chain family member 4 (ACSL4) is an essential component in the promotion of ferroptosis. The present study aimed to investigate the role of ACSL4 and zinc finger translocation-associated protein (ZFTA) in the regulation of endothelial cell ferroptosis in AS. Human umbilical vein endothelial cells (HUVECs) with ACSL4 knockout were generated using CRISPR/Cas9 technology. To assess ferroptosis, malondialdehyde concentration, iron content and reactive oxygen species levels were quantified in the present study. In addition, western blot analysis was conducted to explore the potential mechanisms underlying ACSL4 and ZFTA in the modulation of ferroptosis in HUVECs. The results of the present study demonstrated that the expression levels of ACSL4 and ZFTA were significantly increased in human atherosclerotic plaques. In addition, ACSL4 knockout led to a reduced susceptibility to ferroptosis, while ZFTA contributed to ferroptosis in HUVECs. Results of the present study also demonstrated that ZFTA overexpression upregulated ACSL4 expression in HUVECs, whereas ZFTA knockdown led to decreased ACSL4 expression. Co-transfection experiments demonstrated that the ZTFA overexpression-mediated increase in ferroptosis was reversed following ACSL4 knockdown. Collectively, results of the present study highlighted that ACSL4 mediated the effects of ZFTA on the ferroptosis of HUVECs. Thus, the present study demonstrated the potential role of ACSL4 and ZFTA in the regulation of ferroptosis, and highlighted that ferroptosis-related pathways may act as potential targets in the treatment of AS.
众多研究报道了铁死亡可能参与动脉粥样硬化(AS)的发展。酰基辅酶A合成酶长链家族成员4(ACSL4)是促进铁死亡的关键成分。本研究旨在探讨ACSL4和锌指易位相关蛋白(ZFTA)在AS中对内皮细胞铁死亡调节的作用。利用CRISPR/Cas9技术构建了ACSL4基因敲除的人脐静脉内皮细胞(HUVECs)。本研究对丙二醛浓度、铁含量和活性氧水平进行了定量,以评估铁死亡情况。此外,还进行了蛋白质印迹分析,以探究ACSL4和ZFTA调控HUVECs铁死亡的潜在机制。本研究结果表明,ACSL4和ZFTA的表达水平在人类动脉粥样硬化斑块中显著升高。此外,ACSL4基因敲除导致对铁死亡的易感性降低,而ZFTA则促进HUVECs发生铁死亡。本研究结果还表明,ZFTA过表达上调了HUVECs中ACSL4的表达,而ZFTA敲低则导致ACSL4表达下降。共转染实验表明,ACSL4敲低后可逆转ZTFA过表达介导的铁死亡增加。总体而言,本研究结果突出表明ACSL4介导了ZFTA对HUVECs铁死亡的影响。因此,本研究证明了ACSL4和ZFTA在铁死亡调节中的潜在作用,并强调铁死亡相关途径可能成为AS治疗的潜在靶点。